Yes, there is growing interest in targeting vasoconstriction as part of cancer therapy. Strategies include using agents that normalize blood vessel function or selectively constrict tumor blood vessels to starve the tumor of nutrients while sparing normal tissues. Anti-angiogenic therapies aim to normalize the abnormal vasculature in tumors to improve blood flow and drug delivery.
